Clinical Study Result:

After six months of treatment, the results of this clinical study indicate that Genacol^® AminoLock Collagen may not only reduce discomfort and improve knee function but also prevent joint space degradation.

Maria Lourdes R. Bernardo and Alfredo C. Azarcon, Jr. Effects of Oral Collagen Treatment on the Media Knee Joint Space and Functional Outcome among Veterans Memorial Medical Center Patients Diagnosed with Knee discomfort (2012).

A second clinical study was carried out in a Veterans Hospital Center in the Philippines; this time, the study focused on patients suffering from knee discomfort(12).

A total of 113 patients were randomly assigned to receive either a daily dose of 1200 mg of Genacol® AminoLock^® Collagen or a daily dose of 200 mg of aceclofenac.

The authors used the Western Ontario and MacMaster Universities Index (WOMAC). The latter is often considered the reference test for knee discomfort since it assesses discomfort and joint function in several daily situations of rest and activity (13).

After six months of treatment, the WOMAC score of patients taking Genacol^® AminoLock^® Collagen was significantly reduced, whereas patients taking aceclofenac were not.

This clearly demonstrates that joint discomfort and function were considerably improved by the daily administration of Genacol^® AminoLock^® Collagen, an effect that was significantly superior to the reference NSAID drug.

Â